The implants have been associated with anaplastic large-cell lymphoma, a rare cancer of the immune system. A majority of the cases occurred in women with textured implants manufactured by Allergan. Many other countries have banned the use of textured implants.
However, the FDA said May 2 that there was not enough evidence to justify banning the implants.
“At this time, the FDA does not believe that, on the basis of all available data and information, the device meets the banning standard set forth in the federal Food, Drug and Cosmetic Act,” the FDA said.
More articles on supply chain:
Free 1-day Prime shipping coming soon, Amazon says
A generic version of Narcan, a device for ADHD & more: 6 recent FDA approvals
How the US healthcare system can tackle its sustainability problem
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
